Craft
Illumina

Illumina

Backlog

$1 B

FY, 2022

Revenue

$4.5 B

FY, 2021

Market Capitalization

$31 B

2022-09-21

Illumina Summary

Company summary

Overview
Illumina is a company that develops, manufactures, and markets sequencing- and array-based integrated systems for genetic and genomic analysis. The company provides a line of products and services for DNA sequencing, genotyping, and gene expression applications. Its platforms support the scale of experimentation necessary for population-scale studies, genome-wide discovery, target selection, and validation studies. Illumina also offers instruments and consumables, which include reagents, flow cells, and microarrays. The company serves genomic research centers, pharmaceutical companies, academic institutions, clinical research organizations, government laboratories, hospitals, as well as pharmaceutical, biotechnology, commercial molecular diagnostic laboratories, and consumer genomics companies.
Type
Public
Founded
1998
HQ
San Diego, CA, US | view all locations
Website
https://www.illumina.com/
Cybersecurity rating
ESG rating
out of 100 | View all ESG data
Sectors

Key people

  • Francis deSouza

    Francis deSouza, Chief Executive Officer

  • Susan Tousi

    Susan Tousi, Chief Commercial Officer

  • Kevin Pegels

    Kevin Pegels, Chief of Global Operations

  • Aimee Hoyt

    Aimee Hoyt, Chief People Officer

Operating MetricsView all

Patents (US)

1K
13.1%

FY, 2022

Patent Applications (US)

789
21.4%

FY, 2022

Backlog

$1B
26.8%

FY, 2022

LocationsView all

18 locations detected

  • San Diego, CA HQ

    United States

    5200 Illumina Way

  • Baltimore, MD

    United States

    801 W Baltimore St #500

  • Foster City, CA

    United States

    200 Lincoln Centre Dr

  • Hayward, CA

    United States

    25861 Industrial Blvd

  • Madison, WI

    United States

    524 Genomic Dr

  • San Diego, CA

    United States

    4795 Executive Dr

and 12 others

Illumina Financials

Summary financials

Revenue (Q2, 2022)
$1.2B
Gross profit (Q2, 2022)
$767.0M
Net income (Q2, 2022)
($535.0M)
Cash (Q2, 2022)
$1.3B
EBIT (Q2, 2022)
($579.0M)
Enterprise value
$32.2B

Footer menu